San Diego biotechs expanding ties to China
These days in biotechnology, if you're not already tied in some way to China, you're giving it some serious thought. Over the last few years, San Diego's biotech community has steadily expanded its contacts with researchers in Beijing and Shanghai. Executives from Invitrogen and other biotechs routinely make the 12-hour commute, expanding their footprint in a country that promises to play a leading role in drug development.
"Nowadays you would be hard-pressed to find a decent local biotech that is not using a (foreign contract research organization) or at least seriously considering using a company from China or India," Zhu Shen, head of business development at San Diego-based Immusol, told the San Diego Union-Tribune.
- read the report from the San Diego Union-Tribune
Related Articles:
R&D spending going gangbusters in China. Report
China surges past India in drug discovery work. Report
China pushes drug development as R&D soars. Report
Comments (1) | Post a comment
Comments
By Anonymous | Posted 4:04pm | December 17, 2007
I find this article troubling. China has shown it will take any manner or method to produce product and send this product to U.S..
Lead paint in toys. Does anyone remember that?
False scienitifc information from China on producing drug discovery and methods. Does anyone remember that?
Do these companies believe the american public will accept any drug product from China. I would like to see data of what the american public thinks about the China biotech market and submitting drug product to U.S..
From reading this article, buyer be aware should be the law now.
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
